Product
FLUAD®
1 clinical trial
4 indications
Indication
COVID-19Indication
Seasonal InfluenzaIndication
Respiratory Syncytial VirusIndication
CytomegalovirusClinical trial
Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Modified mRNA Vaccines Using a Systems Biology Approach in Healthy AdultsStatus: Active (not recruiting), Estimated PCD: 2026-02-21